IL161545A0 - Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes - Google Patents

Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes

Info

Publication number
IL161545A0
IL161545A0 IL16154502A IL16154502A IL161545A0 IL 161545 A0 IL161545 A0 IL 161545A0 IL 16154502 A IL16154502 A IL 16154502A IL 16154502 A IL16154502 A IL 16154502A IL 161545 A0 IL161545 A0 IL 161545A0
Authority
IL
Israel
Prior art keywords
pharmaceutical
oxy group
compositions containing
cosmetic compositions
containing oxy
Prior art date
Application number
IL16154502A
Other languages
English (en)
Original Assignee
Cutanix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutanix Corp filed Critical Cutanix Corp
Publication of IL161545A0 publication Critical patent/IL161545A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16154502A 2001-11-16 2002-08-16 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes IL161545A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US33227701P 2001-11-16 2001-11-16
US34604902P 2002-01-04 2002-01-04
US36856502P 2002-04-01 2002-04-01
US36851802P 2002-04-01 2002-04-01
US38458902P 2002-05-30 2002-05-30
US38469002P 2002-05-30 2002-05-30
PCT/US2002/021844 WO2003043621A1 (fr) 2001-11-16 2002-08-16 Compositions pharmaceutiques et cosmetiques contenant des aldehydes aromatiques porteurs de groupes oxy

Publications (1)

Publication Number Publication Date
IL161545A0 true IL161545A0 (en) 2004-09-27

Family

ID=32660228

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16154502A IL161545A0 (en) 2001-11-16 2002-08-16 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
IL161545A IL161545A (en) 2001-11-16 2004-04-21 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161545A IL161545A (en) 2001-11-16 2004-04-21 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes

Country Status (19)

Country Link
EP (1) EP1443915B1 (fr)
JP (2) JP4587669B2 (fr)
KR (1) KR100887601B1 (fr)
CN (2) CN102973417A (fr)
AT (1) ATE330591T1 (fr)
AU (1) AU2002326363B2 (fr)
BR (1) BR0214208A (fr)
CA (1) CA2464867C (fr)
DE (1) DE60212683T2 (fr)
DK (1) DK1443915T3 (fr)
EA (1) EA009281B1 (fr)
ES (1) ES2266554T3 (fr)
IL (2) IL161545A0 (fr)
MX (1) MXPA04004673A (fr)
NZ (1) NZ552216A (fr)
PT (1) PT1443915E (fr)
TW (1) TWI297604B (fr)
WO (1) WO2003043621A1 (fr)
ZA (1) ZA200403282B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
EP1622554A4 (fr) * 2003-05-15 2008-01-02 Bioform Medical Inc Compositions contenant un melange d'un agent pharmaceutique ou d'un agent cosmetique et d'un aldehyde aromatique de support de groupe oxy
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US7129220B2 (en) 2003-08-01 2006-10-31 Janssen Pharmaceutica N.V Substituted indole-O-glucosides
DK2896397T4 (da) 2003-08-01 2020-11-16 Mitsubishi Tanabe Pharma Corp Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør
WO2007002447A2 (fr) * 2005-06-23 2007-01-04 Bioform Medical, Inc. Compositions servant a traiter l'acne rosacee
GB0526283D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Compositions
UY30730A1 (es) 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
ES2647504T3 (es) 2007-09-10 2017-12-21 Janssen Pharmaceutica N.V. Proceso para la preparación de compuestos útiles como inhibidores de SGLT
US9616006B2 (en) 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
CA3006143C (fr) * 2007-10-10 2021-10-19 Therametics, Llc Procedes et compositions utilises pour traiter les maladies et les affections dermatologiques
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN102648196B (zh) 2009-10-14 2016-04-27 詹森药业有限公司 可用作sglt2的抑制剂的化合物的制备方法
CN108354930A (zh) 2010-05-11 2018-08-03 詹森药业有限公司 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂
SG10202009963PA (en) * 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use
US10544135B2 (en) 2011-04-13 2020-01-28 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
JP6061373B2 (ja) * 2012-07-24 2017-01-18 国立研究開発法人産業技術総合研究所 ２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物
CN104473912A (zh) * 2014-11-26 2015-04-01 云南中医学院 对羟基苯甲醛在制备抗炎药物中的用途
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
JP2019116426A (ja) * 2017-12-26 2019-07-18 小林製薬株式会社 歯肉組織の破壊抑制剤
FR3081710A1 (fr) * 2018-05-31 2019-12-06 Bionuclei Molecule enzymatique mimant une activite antioxydante
GB201817785D0 (en) * 2018-10-31 2018-12-19 Givaudan Sa Organic compounds
WO2022128051A1 (fr) * 2020-12-14 2022-06-23 Symrise Ag Médicament pour lutter contre des états inflammatoires de la peau humaine (ii)
WO2022128054A1 (fr) * 2020-12-14 2022-06-23 Symrise Ag Médicament pour lutter contre des états inflammatoires de la peau humaine (iv)

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US414770A (en) * 1889-11-12 Swaging-bench for iron fences
JPS5244375B2 (fr) * 1974-04-19 1977-11-08
DE2519161A1 (de) * 1975-04-30 1976-11-18 Henkel & Cie Gmbh Entzuendungshemmer fuer kosmetische praeparationen
JPS604801B2 (ja) * 1977-11-21 1985-02-06 呉羽化学工業株式会社 抗皮膚真菌剤
JPS5545659A (en) * 1978-09-28 1980-03-31 Rikagaku Kenkyusho Carcinostatic agent
JPS5545656A (en) * 1978-09-28 1980-03-31 Rikagaku Kenkyusho Carcinostatic agent
JPS5612310A (en) * 1979-07-10 1981-02-06 Rikagaku Kenkyusho Carcinostatic agent
GB8501646D0 (en) * 1985-01-23 1985-02-27 Nipa Lab Ltd Control of micro-organisms
US4714609A (en) * 1986-07-21 1987-12-22 Laverne Stanley Skin tanning composition
JPH085780B2 (ja) * 1989-04-28 1996-01-24 呉羽化学工業株式会社 変形性関節症治療剤
CA2017923A1 (fr) * 1989-06-06 1990-12-06 Gordon Francis Brunner Composes d'antitussifs pour administration orale
GB9026080D0 (en) * 1990-11-30 1991-01-16 Norsk Hydro As Pharmaceutical compositions
JP3057207B2 (ja) * 1991-09-03 2000-06-26 株式会社資生堂 皮膚外用剤
US5378468A (en) * 1992-09-22 1995-01-03 The Mennen Company Composition containing body activated fragrance for contacting the skin and method of use
JPH072640A (ja) * 1992-10-29 1995-01-06 Marino Forum 21 紫外線障害防御外用剤
JPH06329516A (ja) * 1993-05-21 1994-11-29 Mikimoto Pharmaceut Co Ltd 化粧料
GB9314929D0 (en) * 1993-07-19 1993-09-01 Charwell Consumer Prod Louse repellent compositions
JPH07242558A (ja) * 1994-03-05 1995-09-19 Tomoji Tanaka 床ズレ防止剤添加体
JP3665360B2 (ja) * 1994-05-02 2005-06-29 ポーラ化成工業株式会社 活性酸素消去剤及びこれを含む組成物
US5614179A (en) * 1995-09-27 1997-03-25 Church & Dwight Co., Inc. Cosmetic deodorant products containing a polymer/fragrance-encapsulated bicarbonate ingredient
US5733535A (en) * 1995-10-25 1998-03-31 The Procter & Gamble Co. Topical compositions containing N-acetylcysteine and odor masking materials
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5766575A (en) * 1996-06-14 1998-06-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method and composition for skin lightening
US5668182A (en) * 1996-08-19 1997-09-16 Virginia Commonwealth University Method of calming or sedating an animal with a hydroxy benzaldehyde compound
US6126930A (en) * 1997-02-13 2000-10-03 The Procter & Gamble Company Spray compositions
US6204229B1 (en) * 1997-03-18 2001-03-20 Kao Corporation Composition to be applied to hair or skin
US6214879B1 (en) * 1998-03-24 2001-04-10 Virginia Commonwealth University Allosteric inhibitors of pyruvate kinase
DE19841796A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden
JP2001106639A (ja) * 1999-10-04 2001-04-17 Taisho Pharmaceut Co Ltd 経口用組成物

Also Published As

Publication number Publication date
BR0214208A (pt) 2004-10-26
NZ552216A (en) 2008-07-31
DE60212683T2 (de) 2007-06-28
AU2002326363B2 (en) 2008-08-28
IL161545A (en) 2010-11-30
CA2464867A1 (fr) 2003-05-30
TWI297604B (en) 2008-06-11
DK1443915T3 (da) 2006-10-23
JP2005509662A (ja) 2005-04-14
PT1443915E (pt) 2006-11-30
ES2266554T3 (es) 2007-03-01
DE60212683D1 (de) 2006-08-03
ZA200403282B (en) 2005-05-03
EA200400689A1 (ru) 2005-02-24
KR20050018633A (ko) 2005-02-23
MXPA04004673A (es) 2005-05-17
EP1443915B1 (fr) 2006-06-21
KR100887601B1 (ko) 2009-03-13
CN102973417A (zh) 2013-03-20
EA009281B1 (ru) 2007-12-28
ATE330591T1 (de) 2006-07-15
EP1443915A1 (fr) 2004-08-11
CA2464867C (fr) 2014-01-28
AU2002326363A1 (en) 2003-06-10
JP2010059203A (ja) 2010-03-18
TW200406195A (en) 2004-05-01
JP4587669B2 (ja) 2010-11-24
WO2003043621A1 (fr) 2003-05-30
CN1589136A (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
IL161545A (en) Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
AU747599C (en) Antitumor agents
WO2001070210A3 (fr) Procedes permettant d'ameliorer la taille et l'aspect d'une blessure
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
AU5931101A (en) Topical composition for the treatment of psoriasis and related skin disorders
WO2002080890A3 (fr) Composition pharmaceutique de jasmonate pour le traitement du cancer
NO20052494D0 (no) Preparater inneholdende melatonin, gingko biloba og biotin.
WO2004037235A3 (fr) Methode et composition destinees a la prevention de l'apparition et au traitement de tumeurs solides
IS6319A (is) Indólýl-3-glýoxý sýru afleiður sem innihalda gagnlega meðferðarlega eiginleika
MXPA05012753A (es) Composiciones cosmeticas estables que comprenden un agente autobronceador.
CA2441461A1 (fr) Formulations en application locale pour l'administration transdermique de niacine, et procedes pour traiter l'hyperlipemie
WO2001066551A3 (fr) Composes azole comme agents therapeutiques pour traiter des infections mycosiques
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
WO2002062334A3 (fr) Composes de chimioprevention des cancers et compositions et procedes de traitement des cancers
FR2803513B1 (fr) Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
PL360297A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
BR0009194A (pt) Composição do resorcinol
BR0115983A (pt) Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma
ATE259638T1 (de) Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
DE60003189T2 (de) Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält
IT1314274B1 (it) Composizione dermatologica per il trattamento topico di malattiecutanee.
GR1003969B (el) Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
IT1304342B1 (it) Composizione per il trattamento cosmetico topico della cellulite.
IT1312375B1 (it) Composizione topica per l'eliminazione di tatuaggi.